T. Denny Sanford donates $50 million to Burnham Institute for Medical Research

January 26, 2010

LA JOLLA, Calif., January 26, 2010 - Burnham Institute for Medical Research (Burnham) announced today that philanthropist T. Denny Sanford has pledged $50 million to support and further expand and accelerate the Institute's leading-edge medical research. To honor Sanford, Burnham, has been renamed the Sanford-Burnham Medical Research Institute. This is the second gift Sanford has made to Burnham. In 2007, he directed $20 million through Sanford Health to create the Sanford Children's Health Research Center at Burnham.

"Denny Sanford's continuing generosity will help us make a greater impact on human health," said John C. Reed, M.D., Ph.D., President and CEO, professor and Donald Bren Presidential Chair. "Medical research is changing rapidly. This gift provides a base that enhances our ability to innovate, allowing us to create and maintain technological capabilities that empower great science and also providing seed funding for new ideas that generate promising pilot results so critical for competitive grant applications. At the other end of the spectrum, this remarkable gift provides much-needed support for translating our discoveries into novel strategies for prevention, diagnosis and therapy of diseases."

The Sanford gift will significantly strengthen Burnham's endowment. While Burnham has been extremely successful at winning grant support from the National Institutes of Health (NIH), achieving eight consecutive years of double-digit growth in grant revenue and currently ranking fourth in the nation among similar organizations, philanthropy provides funding for initiatives not typically supported by the NIH and ensures stability in an increasingly competitive grant environment. The gift will be made in $10 million increments for five years.

"Since the Sanford Children's Health Research Center was established, I have had the opportunity to observe the incredible research being conducted by Burnham scientists," said Denny Sanford. "With this gift I have challenged others to join me in supporting this life-changing science."

Malin Burnham, whose own gift catalyzed a similar transformation in 1996, welcomes the change and the challenge. "We are all honored by the confidence Denny Sanford has shown in the Institute," said Burnham. "These additional resources will help our scientists address many of the world's most devastating diseases faster, and that will benefit patients."

In less than two and a half years, Denny Sanford has invested $100 million in San Diego life-science organizations. Sanford has given Burnham, both individually and through Sanford Health, $70 million. In 2008, Sanford donated $30 million to the San Diego Consortium for Regenerative Medicine, now known as the Sanford Consortium for Regenerative Medicine, to construct its state-of-the-art stem cell research facility. Burnham is a member of the Consortium.

"This gift will bring long-term benefits to our bicoastal Institute operating in California and Florida, our many collaborators, and millions suffering from disease," said Greg Lucier, Chairman of the Burnham Board of Trustees and CEO of Life Technologies Corporation.

"California is home to the world's finest biotechnology businesses and institutions that are not only producing a healthier tomorrow but also providing hundreds of thousands of jobs and generating tens of billions of dollars in economic impact in our state today," said California Governor Arnold Schwarzenegger. "I applaud Denny Sanford for his generous donations to this industry and to the Burnham Institute's cutting-edge research. Discoveries being made by our biomedical research community have already given millions help and hope, and I look forward to the life-enhancing results and new jobs created by this partnership."
-end-
About Sanford-Burnham Medical Research Institute

Sanford-Burnham Medical Research Institute (Sanford-Burnham), formerly Burnham Institute for Medical Research, is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country. The Institute ranks among the top independent research institutions nationally for NIH grant funding and among the top organizations worldwide for its research impact. From 1999 - 2009, Sanford-Burnham ranked #1 worldwide among all types of organizations in the fields of biology and biochemistry for the impact of its research publications, defined by citations per publication, according to the Institute for Scientific Information. According to government statistics, Sanford-Burnham ranks #2 nationally among all organizations in capital efficiency of generating patents, defined by number of patents issued per grant dollars awarded.

Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a nonprofit public benefit corporation. For more information, please visit www.burnham.org.

About T. Denny Sanford

Denny Sanford was born in St. Paul, Minnesota, at the height of the Great Depression. He started working at the age of eight. He earned a degree in psychology from the University of Minnesota, Twin Cities and began a career in sales and marketing management. In 1966, Sanford started Contech, a specialty chemical company which was sold in 1982 and followed by a career in private equity investments. In 1986, he purchased United National Bank, which was renamed First Premier Bank. Under his leadership, First Premier has grown its assets to almost $1 billion. Another business, Premier Bankcard Inc., which he started, has become a national leader in the credit card industry.

In 2001, Sanford formed the Sanford Foundation. He is now recognized as one of the most generous philanthropists in the country. In 2007, Sanford donated $470 million to South Dakota-based Sioux Valley Hospitals & Health System to create Sanford Health. Later that year, he donated $20 million through Sanford Health to Burnham Institute for Medical Research to create the Sanford Children's Health Research Center. The following year he donated $30 million to the San Diego Stem Cell Consortium, now the Sanford Consortium for Regenerative Medicine. His newest gift to Sanford-Burnham brings his total philanthropic investment in San Diego to $100 million. Sanford is now a part-time San Diegan.

Sanford-Burnham Prebys Medical Discovery Institute

Related Regenerative Medicine Articles from Brightsurf:

Stem cells: new insights for future regenerative medicine approaches
The study published in Open Biology unravels important data for a better understanding of the process of division in stem cells and for the development of safer ways to use them in medicine.

Engineered developmental signals could illuminate regenerative medicine
For a tiny embryo to develop into an adult organism, its cells must develop in precise patterns and interact with their neighbors in carefully orchestrated ways.

A new discovery in regenerative medicine
An international collaboration involving Monash University and Duke-NUS researchers have made an unexpected world-first stem cell discovery that may lead to new treatments for placenta complications during pregnancy.

New research into stem cell mutations could improve regenerative medicine
Research from the University of Sheffield has given new insight into the cause of mutations in pluripotent stem cells and potential ways of stopping these mutations from occurring.

Keratin scaffolds could advance regenerative medicine and tissue engineering for humans
Researchers at Mossakowski Medical Research Center of the Polish Academy of Science have developed a simple method for preparing 3D keratin scaffold models which can be used to study the regeneration of tissue.

NUS Medicine researchers can reprogramme cells to original state for regenerative medicine
Scientists from NUS Medicine have found a way to induce totipotency in embryonic cells that have already matured into pluripotency.

A new material for regenerative medicine capable to control cell immune response
Scientists of Tomsk Polytechnic University jointly with the University of Montana (USA) proposed a new promising material for regenerative medicine for recovery of damaged tissues and blood vessels.

Optoceutics: A new technique using light for regenerative medicine
Researchers in Italy at IIT-Istituto Italiano di Tecnologia used visible light together with photo-sensitive and biocompatible materials to facilitate the formation of new blood vessels in vitro.

Major stem cell discovery to boost research into development and regenerative medicine
A new approach has enabled researchers to create Expanded Potential Stem Cells (EPSCs) of both pig and human cells.

Spinning-prism microscope helps gather stem cells for regenerative medicine
Pluripotent stem cells are crucial to regenerative medicine, but better screening methods are needed to isolate safe and effective cells for medical use.

Read More: Regenerative Medicine News and Regenerative Medicine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.